President Trump is set to announce on Monday that more medications will be available through TrumpRx, the administration's discounted-drug website, at an afternoon White House healthcare affordability event. A White House official previewed the remarks on condition of anonymity.
The expansion adds to a service that launched in February with over 40 medications, including weight-loss drugs such as Ozempic and Wegovy. TrumpRx is not a place where people buy medicine directly from the government. Instead, the site points Americans to drugmakers' direct-to-consumer websites to make purchases and also offers coupons that can be used at pharmacies.
The new offerings arrive as affordability has become one of the sharpest concerns for voters heading into the November midterm elections. Democrats have seized on the issue, and last month Sen. Elizabeth Warren of Massachusetts called TrumpRx a “conduit for Big Pharma to steer consumers to expensive brand-name drugs when cheaper generics are available.”
The administration has tried to frame the website as part of a broader push to lower drug costs, including deals struck with 17 major drugmakers to offer medications at the same prices seen in other developed countries, or lower. That effort has given Trump a fresh talking point on an issue that cuts across party lines, but it also leaves his signature drug-price website exposed to criticism that it channels customers toward pricier brand-name treatments rather than cheaper alternatives.
What happens next is whether the new TrumpRx lineup gives the White House a cleaner argument on costs or just gives critics a larger target. For now, the president is betting that more choices, plus the promise of lower prices, will resonate with consumers who have watched health expenses remain stubbornly high.
